Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia-Reference-Cited by-同舟云学术

Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia

Published:1998-08 Issue:2 Volume:139 Page:401-409
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Park Jai-Wun,Merz Mechthild,Braun Peter

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–1389.

2. European Atherosclerosis Society International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992;2:113–156

3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993;269:3015–3020.

4. Plasma exchange in the management of homozygous familial hypercholesterolemia;Thompson;Lancet,1975

5. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia;Stoffel;Lancet,1981

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term Effect of LDL-Apheresis on Lipid Profile of Patients with Nephrotic and Non-Nephrotic Hyperlipidemia: A Comparative Study;Electronic Journal of General Medicine;2021-04-27

2. HELP-(Heparin-induced Extracorporeal LDL Precipitation)-apheresis in heart recipients with cardiac allograft vasculopathy and concomitant hypercholesterolemia: Influence of long-term treatment on the microcirculation;Clinical Hemorheology and Microcirculation;2019-11-13

3. Pleiotropic Effect of Lipoprotein-Apheresis on the Soluble Form of Activated Leukocyte Cell Adhesion Molecule (sALCAM) in Familial Hypercholesterolaemia;Experimental and Clinical Endocrinology & Diabetes;2018-06-11

4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue;Journal of Clinical Apheresis;2013-06

5. Role of apheresis in the management of familial hypercholesterolemia and elevated Lp(a) levels;Clinical Lipidology;2011-10-01